AINO HEALTH AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.365 SEK | -4.20% |
|
-18.34% | -10.98% |
| Mar. 05 | Steveco Oy Implements Aino Health?S Saas-Solution for 800 Employees | CI |
| Feb. 23 | Aino Health AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 28.2 | 34.26 | 94.34 | 59.49 | 20.66 | 75.48 |
| Enterprise Value (EV) 1 | 19.8 | 23.8 | 91.66 | 51.98 | 21.27 | 73.98 |
| P/E ratio | -0.89 x | -0.79 x | -6.18 x | -3.2 x | -1.28 x | -4.89 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.46 x | 1.65 x | 3.65 x | 2.39 x | 0.9 x | 3.79 x |
| EV / Revenue | 1.03 x | 1.15 x | 3.54 x | 2.09 x | 0.92 x | 3.72 x |
| EV / EBITDA | -0.68 x | -1.27 x | -7.41 x | -4.31 x | -1.72 x | -5.85 x |
| EV / FCF | -1.26 x | -1.24 x | -140 x | -7.76 x | -5.08 x | -22.7 x |
| FCF Yield | -79.1% | -80.4% | -0.71% | -12.9% | -19.7% | -4.41% |
| Price to Book | 1.28 x | 1.15 x | 6.52 x | 3.71 x | 8.02 x | -33.8 x |
| Nbr of stocks (in thousands) | 5,423 | 15,934 | 15,935 | 26,558 | 26,901 | 42,286 |
| Reference price 2 | 5.200 | 2.150 | 5.920 | 2.240 | 0.7680 | 1.785 |
| Announcement Date | 5/7/18 | 4/18/19 | 5/25/20 | 4/20/21 | 4/20/22 | 4/30/23 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 19.25 | 20.75 | 25.87 | 24.92 | 23.04 | 19.91 |
| EBITDA 1 | -29.14 | -18.76 | -12.36 | -12.06 | -12.4 | -12.65 |
| EBIT 1 | -30.95 | -20.65 | -14.41 | -13.98 | -14.23 | -14.56 |
| Operating Margin | -160.76% | -99.52% | -55.68% | -56.1% | -61.76% | -73.12% |
| Earnings before Tax (EBT) 1 | -31.79 | -22 | -15.27 | -13.17 | -15.22 | -14.96 |
| Net income 1 | -31.79 | -22.01 | -15.28 | -13.17 | -15.22 | -14.96 |
| Net margin | -165.13% | -106.03% | -59.04% | -52.84% | -66.05% | -75.16% |
| EPS 2 | -5.862 | -2.726 | -0.9586 | -0.7000 | -0.6000 | -0.3651 |
| Free Cash Flow 1 | -15.66 | -19.15 | -0.654 | -6.7 | -4.19 | -3.265 |
| FCF margin | -81.37% | -92.25% | -2.53% | -26.89% | -18.18% | -16.4% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/7/18 | 4/18/19 | 5/25/20 | 4/20/21 | 4/20/22 | 4/30/23 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 0.61 | - |
| Net Cash position 1 | 8.39 | 10.5 | 2.68 | 7.51 | - | 1.5 |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.049 x | - |
| Free Cash Flow 1 | -15.7 | -19.1 | -0.65 | -6.7 | -4.19 | -3.26 |
| ROE (net income / shareholders' equity) | -84.4% | -84.9% | -68.9% | -86.4% | -164% | -8,724% |
| ROA (Net income/ Total Assets) | -40.8% | -37.2% | -26.7% | -27.8% | -34% | -50.1% |
| Assets 1 | 77.85 | 59.2 | 57.24 | 47.31 | 44.82 | 29.89 |
| Book Value Per Share 2 | 4.050 | 1.870 | 0.9100 | 0.6000 | 0.1000 | -0.0500 |
| Cash Flow per Share 2 | 1.710 | 0.7200 | 0.1900 | 0.3400 | 0.0200 | 0.0500 |
| Capex | - | - | 0.23 | - | - | - |
| Capex / Sales | - | - | 0.88% | - | - | - |
| Announcement Date | 5/7/18 | 4/18/19 | 5/25/20 | 4/20/21 | 4/20/22 | 4/30/23 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.98% | 2.82M | |
| +10.55% | 67.6B | |
| +11.64% | 18.21B | |
| +21.03% | 13.41B | |
| +9.40% | 13.37B | |
| +16.53% | 9.94B | |
| -32.90% | 5.74B | |
| -10.98% | 5.57B | |
| -4.09% | 4.91B | |
| -4.83% | 4.87B |
- Stock Market
- Equities
- AINO Stock
- Financials Aino Health AB
